Literature DB >> 23876548

Association between low SIRT1 expression in visceral and subcutaneous adipose tissues and metabolic abnormalities in women with obesity and type 2 diabetes.

Young Sook Song1, Seul Ki Lee, Yeon Jin Jang, Hye Soon Park, Jong-Hyeok Kim, Yeon Ji Lee, Yoon-Suk Heo.   

Abstract

AIMS: To assess the importance of adipose tissue sirtuin 1 (SIRT1) in the regulation of whole-body metabolism in humans with obesity and type 2 diabetes.
METHODS: In total, 19 non-diabetic obese women, 19 type 2 diabetic women undergoing gastric bypass surgery, and 27 normal-weight women undergoing gynecological surgery (total 65 women) were enrolled. Their anthropometric variables, abdominal fat distribution and metabolic parameters, serum adiponectin concentrations, and SIRT1 mRNA and protein and adiponectin mRNA expressions in visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were measured.
RESULTS: SIRT1 mRNA levels in VAT and SAT were similar and these levels were suppressed in obese and type 2 diabetic women compared to normal-weight subjects. These decreases in SIRT1 expression were observed in both adipocytes and non-fat cells. There was a strong association between adipose tissue SIRT1 mRNA and protein levels. Adipose SIRT1 expression correlated inversely with HOMA-IR and other insulin resistance-related parameters. Adipose SIRT1 and adiponectin mRNA expression correlated very strongly and positively. SIRT1 mRNA level in VAT correlated inversely with visceral obesity whereas its expression in SAT correlated negatively with body mass index.
CONCLUSIONS: Adipose tissue SIRT1 may play a key role in the regulation of whole body metabolic homeostasis in humans. Downregulation of SIRT1 in VAT may contribute to the metabolic abnormalities that are associated with visceral obesity.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adiponectin; Adipose tissue; Insulin resistance; SIRT1; Visceral obesity

Mesh:

Substances:

Year:  2013        PMID: 23876548     DOI: 10.1016/j.diabres.2013.07.002

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  24 in total

1.  Prostaglandin E2 down-regulates sirtuin 1 (SIRT1), leading to elevated levels of aromatase, providing insights into the obesity-breast cancer connection.

Authors:  Kotha Subbaramaiah; Neil M Iyengar; Monica Morrow; Olivier Elemento; Xi Kathy Zhou; Andrew J Dannenberg
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

2.  Reduced SIRT1 and SIRT2 expression promotes adipogenesis of human visceral adipose stem cells and associates with accumulation of visceral fat in human obesity.

Authors:  Sebastio Perrini; Stefania Porro; Pasquale Nigro; Angelo Cignarelli; Cristina Caccioppoli; Valentina Annamaria Genchi; Gennaro Martines; Michele De Fazio; Palma Capuano; Annalisa Natalicchio; Luigi Laviola; Francesco Giorgino
Journal:  Int J Obes (Lond)       Date:  2019-08-28       Impact factor: 5.095

3.  Adipose-specific knockdown of Sirt1 results in obesity and insulin resistance by promoting exosomes release.

Authors:  Fang Li; Huixia Li; Xinxin Jin; Ying Zhang; Xiaomin Kang; Zhuanmin Zhang; Mao Xu; Zhuang Qian; Zhengmin Ma; Xin Gao; Liting Zhao; Shufang Wu; Hongzhi Sun
Journal:  Cell Cycle       Date:  2019-07-11       Impact factor: 4.534

4.  SIRT1 and SIRT7 expression in adipose tissues of obese and normal-weight individuals is regulated by microRNAs but not by methylation status.

Authors:  A Kurylowicz; M Owczarz; J Polosak; M I Jonas; W Lisik; M Jonas; A Chmura; M Puzianowska-Kuznicka
Journal:  Int J Obes (Lond)       Date:  2016-08-02       Impact factor: 5.095

5.  Sirtuins 1-7 expression in human adipose-derived stem cells from subcutaneous and visceral fat depots: influence of obesity and hypoxia.

Authors:  Stefania Mariani; Giuliana Di Rocco; Gabriele Toietta; Matteo A Russo; Elisa Petrangeli; Luisa Salvatori
Journal:  Endocrine       Date:  2016-11-14       Impact factor: 3.633

Review 6.  Adipose tissue NAD+ biology in obesity and insulin resistance: From mechanism to therapy.

Authors:  Shintaro Yamaguchi; Jun Yoshino
Journal:  Bioessays       Date:  2017-03-15       Impact factor: 4.345

7.  Plasma levels of SIRT1 associate with non-alcoholic fatty liver disease in obese patients.

Authors:  Stefania Mariani; Daniela Fiore; Sabrina Basciani; Agnese Persichetti; Savina Contini; Carla Lubrano; Luisa Salvatori; Andrea Lenzi; Lucio Gnessi
Journal:  Endocrine       Date:  2014-10-31       Impact factor: 3.633

Review 8.  Sirtuins as novel players in the pathogenesis of diabetes mellitus.

Authors:  Kultigin Turkmen; Ali Karagoz; Adem Kucuk
Journal:  World J Diabetes       Date:  2014-12-15

Review 9.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

10.  Circulating SIRT1 Increases After Intragastric Balloon Fat Loss in Obese Patients.

Authors:  Stefania Mariani; Daniela Fiore; Agnese Persichetti; Sabrina Basciani; Carla Lubrano; Eleonora Poggiogalle; Alfredo Genco; Lorenzo Maria Donini; Lucio Gnessi
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.